Click a link below to view the mailing archive as if it had been sent to you.
| 2023-04-28 12:15 | | Amgen cuts lupus programs for futility, hours after Lilly officially walks away from one too and more... |
| 2023-04-28 00:15 | | Merck beats first-quarter expectations on Keytruda, Gardasil strength and more... |
| 2023-04-27 12:15 | | FDA approves first oral microbiome therapy Vowst and more... |
| 2023-04-27 00:15 | | Bristol Myers CEO Caforio steps down and more... |
| 2023-04-26 12:15 | | US Senate kicks off fresh round of drug pricing control legislation and more... |
| 2023-04-26 00:15 | | FDA approves Biogen and Ionis’ Tofersen for rare genetic form of ALS and more... |
| 2023-04-25 12:15 | | Busy with 3 program launches this year, Biogen trims pipeline and more... |
| 2023-04-25 00:15 | | Pharma is clearly not done fighting drug-pricing reforms and more... |
| 2023-04-24 12:15 | | Big Pharma’s R&D spending flatlined in 2022: What it means for the industry and more... |
| 2023-04-21 12:15 | | Lilly expects US Medicare to reverse course, fully cover Alzheimer's drugs and more... |
| 2023-04-21 00:15 | | After pandemic delays, FDA still struggling to inspect foreign drug manufacturers and more... |
| 2023-04-20 12:15 | | Twist Bioscience Enters into Third Collaboration with Astellas to Support Antibody Discovery for Immunotherapies and more... |
| 2023-04-20 00:15 | | GSK faces strike threat in UK, again, after workers pan pay raise and more... |
| 2023-04-19 12:15 | | Abbott sales 18% fall due to anticipation of COVID testing sales declines and more... |
| 2023-04-19 00:15 | | FDA amends COVID vaccine EUAs, considers animal studies to accelerate updates and more... |
| 2023-04-18 12:15 | | GSK coughs up $2B for Bellus Health and more... |
| 2023-04-18 00:15 | | Teva's Partner Alvotech Receives Complete Response Letter For AVT02 BLA and more... |
| 2023-04-17 12:15 | | Talaris lays off 95% of workforce, C-suite as kidney transplant company fails to find a savior and more... |
| 2023-04-17 00:15 | | Merck to buy inflammatory disease drugmaker Prometheus for $10.8B and more... |
| 2023-04-14 12:15 | | FDA rejects Teva’s high-potency biosimilar of Humira again and more... |
| 2023-04-14 00:15 | | Medtech sector poised for growth as healthcare staffing tops pre-COVID levels and more... |
| 2023-04-13 12:15 | | Bridge doses first patient in Phase lla trial of IPF therapy and more... |
| 2023-04-13 00:15 | | Pragmatica: Lung cancer trial tests streamlined design, inclusive eligibility and more... |
| 2023-04-12 12:15 | | California bill would mandate HPV vaccine for incoming college students and more... |
| 2023-04-12 00:15 | | A new biotech wants to ease a bottleneck in cell and gene therapy production and more... |
| 2023-04-11 12:15 | | Sanofi's Provention buyout hit with FTC delay. Will Pfizer's Seagen deal go off as planned? and more... |
| 2023-04-11 00:15 | | After 2022's M&A spree, Amgen CEO Bradway collects $21.4M payday and more... |
| 2023-04-10 12:15 | | Big Pharma-partnered Evotec on high alert after cyber attack takes systems offline and more... |
| 2023-04-08 00:15 | | Breaking the mold: How digital endpoints could transform clinical trials and more... |
| 2023-04-06 12:15 | | Q1 claimed the highest number of trial starts in 2022 and more... |
| 2023-04-06 00:15 | | In NEJM, full Pfizer data show RSV vaccine’s protection and more... |
| 2023-04-05 12:15 | | In a refreshingly transparent disclosure, NGM Bio CEO reveals what led to 33% head count reduction and more... |
| 2023-04-05 00:15 | | As market stays cold, biotechs continue to cut programs, trials and staff and more... |
| 2023-04-04 12:15 | | Pharma fees to European regulator spike thanks to 10% inflation rate and more... |
| 2023-04-04 00:15 | | 5 FDA decisions to watch in the second quarter and more... |
| 2023-04-03 12:15 | | FTC orders Illumina to divest $7.1 billion acquisition of cancer test developer Grail and more... |
| 2023-04-03 00:15 | | Pharma partner Sartorius eyes gene therapy market with $2.6B deal and more... |
